https://invesbrain.com/immunogenicity-and-safety-of-an-escherichia-coli-produced-human-papillomavirus-types-6-11-16-18-31-33-45-52-58-l1-virus-like-particle-vaccine-a-phase-2-double-blind-randomized-controlled-trial/
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial